Pancreatic cancer remains one of the most deadly malignancies, with nearly 52,000 deaths expected this year.  With limited therapeutic advances made i | Cancer ...

Castleman disease is an idiopathic, rare lymphoproliferative disorder. It is classified as multicentric Castleman disease, ...

Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Now, research ...

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...

A recent study published by Rutgers Health experts in the European Respiratory Journal identified interconnected webs of ...

Stem cell rejuvenation is a process in which stem cells are used to repair or replace cells in the body that have become ...

Castleman disease (CD) is a rare, non-clonal lymphoproliferative disorder that manifests with a wide range of histologic and ...

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has uncovered a key mechanism behind lenalidomide resistance ...